BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27177854)

  • 1. Re: Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
    Priola AM; Priola SM
    Clin Radiol; 2016 Jul; 71(7):713-5. PubMed ID: 27177854
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT. A reply.
    Yabuuchi H
    Clin Radiol; 2016 Jul; 71(7):711-3. PubMed ID: 27174205
    [No Abstract]   [Full Text] [Related]  

  • 3. Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
    Yabuuchi H; Matsuo Y; Abe K; Baba S; Sunami S; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Nagao M; Okamoto T; Nakamura K; Yamamoto H; Sasaki M; Honda H
    Clin Radiol; 2015 Nov; 70(11):1289-98. PubMed ID: 26272529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
    van Ufford HM; Kwee TC; Beek FJ; van Leeuwen MS; Takahara T; Fijnheer R; Nievelstein RA; de Klerk JM
    AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
    Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
    J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary lymphoma involving cranial nerves and cauda equina detected by (18)F-FDG PET/CT and MRI.
    Wang G; Liu Y; He F
    Nuklearmedizin; 2016 Sep; 55(5):N46-8. PubMed ID: 27668300
    [No Abstract]   [Full Text] [Related]  

  • 8. Mediastinal paraganglioma.
    Takashima Y; Kamitani T; Kawanami S; Nagao M; Yonezawa M; Yamasaki Y; Baba S; Yabuuchi H; Hida T; Kohashi K; Nakamura K; Sonoda H; Oda Y; Honda H
    Jpn J Radiol; 2015 Jul; 33(7):433-6. PubMed ID: 26025611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary comparison of diffusion-weighted MRI and PET/CT in predicting histological type and malignancy of lung cancer.
    Liu LP; Zhang XX; Cui LB; Li J; Yang JL; Yang HN; Zhang Y; Zhou Y; Tang X; Qi S; Fang Y; Zhang J; Yin H
    Clin Respir J; 2017 Mar; 11(2):151-158. PubMed ID: 25918835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic carcinoid mimicking mediastinal lymphoma on
    Liu H; Liu L; Chen Y
    J Nucl Cardiol; 2021 Jun; 28(3):1193-1195. PubMed ID: 32236838
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT.
    Calistri L; Puccini B; Berti V; Grazzini G; Nardi C; Rigacci L; Colagrande S
    Acta Haematol; 2018; 139(2):74-76. PubMed ID: 29393082
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
    Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
    Abdulqadhr G; Molin D; Aström G; Suurküla M; Johansson L; Hagberg H; Ahlström H
    Acta Radiol; 2011 Mar; 52(2):173-80. PubMed ID: 21498346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
    Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM
    Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and functional imaging of thymic and mediastinal involvement in lymphoproliferative disorders.
    Priola AM; Galetto G; Priola SM
    Clin Imaging; 2014; 38(6):771-84. PubMed ID: 24997534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
    Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Staudenherz A; Senn D; Raderer M; Weber M; Simonitsch-Klupp I; Mayerhoefer ME
    PLoS One; 2016; 11(10):e0164118. PubMed ID: 27723817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
    Herrmann K; Queiroz M; Huellner MW; de Galiza Barbosa F; Buck A; Schaefer N; Stolzman P; Veit-Haibach P
    BMC Cancer; 2015 Dec; 15():1002. PubMed ID: 26699124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.